IDEAS home Printed from https://ideas.repec.org/a/spr/drugsa/v46y2023i8d10.1007_s40264-023-01323-2.html
   My bibliography  Save this article

Automatic Extraction of Comprehensive Drug Safety Information from Adverse Drug Event Narratives in the Korea Adverse Event Reporting System Using Natural Language Processing Techniques

Author

Listed:
  • Siun Kim

    (Biomedical Research Institute, Seoul National University Hospital)

  • Taegwan Kang

    (Seoul National University
    LG AI Research)

  • Tae Kyu Chung

    (Seoul National University)

  • Yoona Choi

    (Seoul National University)

  • YeSol Hong

    (Seoul National University)

  • Kyomin Jung

    (Seoul National University)

  • Howard Lee

    (Seoul National University
    Seoul National University
    Seoul National University College of Medicine and Hospital
    Advanced Institutes of Convergence Technology)

Abstract

Introduction Concerns have been raised over the quality of drug safety information, particularly data completeness, collected through spontaneous reporting systems (SRS), although regulatory agencies routinely use SRS data to guide their pharmacovigilance programs. We expected that collecting additional drug safety information from adverse event (ADE) narratives and incorporating it into the SRS database would improve data completeness. Objective The aims of this study were to define the extraction of comprehensive drug safety information from ADE narratives reported through the Korea Adverse Event Reporting System (KAERS) as natural language processing (NLP) tasks and to provide baseline models for the defined tasks. Methods This study used ADE narratives and structured drug safety information from individual case safety reports (ICSRs) reported through KAERS between 1 January 2015 and 31 December 2019. We developed the annotation guideline for the extraction of comprehensive drug safety information from ADE narratives based on the International Conference on Harmonisation (ICH) E2B(R3) guideline and manually annotated 3723 ADE narratives. Then, we developed a domain-specific Korean Bidirectional Encoder Representations from Transformers (KAERS-BERT) model using 1.2 million ADE narratives in KAERS and provided baseline models for the task we defined. In addition, we performed an ablation experiment to investigate whether named entity recognition (NER) models were improved when a training dataset contained more diverse ADE narratives. Results We defined 21 types of word entities, six types of entity labels, and 49 types of relations to formulate the extraction of comprehensive drug safety information as NLP tasks. We obtained a total of 86,750 entities, 81,828 entity labels, and 45,107 relations from manually annotated ADE narratives. The KAERS-BERT model achieved F1-scores of 83.81 and 76.62% on the NER and sentence extraction tasks, respectively, while outperforming other baseline models on all the NLP tasks we defined except the sentence extraction task. Finally, utilizing the NER model for extracting drug safety information from ADE narratives resulted in an average increase of 3.24% in data completeness for KAERS structured data fields. Conclusions We formulated the extraction of comprehensive drug safety information from ADE narratives as NLP tasks and developed the annotated corpus and strong baseline models for the tasks. The annotated corpus and models for extracting comprehensive drug safety information can improve the data quality of an SRS database.

Suggested Citation

  • Siun Kim & Taegwan Kang & Tae Kyu Chung & Yoona Choi & YeSol Hong & Kyomin Jung & Howard Lee, 2023. "Automatic Extraction of Comprehensive Drug Safety Information from Adverse Drug Event Narratives in the Korea Adverse Event Reporting System Using Natural Language Processing Techniques," Drug Safety, Springer, vol. 46(8), pages 781-795, August.
  • Handle: RePEc:spr:drugsa:v:46:y:2023:i:8:d:10.1007_s40264-023-01323-2
    DOI: 10.1007/s40264-023-01323-2
    as

    Download full text from publisher

    File URL: http://link.springer.com/10.1007/s40264-023-01323-2
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.

    File URL: https://libkey.io/10.1007/s40264-023-01323-2?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    References listed on IDEAS

    as
    1. Abhyuday Jagannatha & Feifan Liu & Weisong Liu & Hong Yu, 2019. "Overview of the First Natural Language Processing Challenge for Extracting Medication, Indication, and Adverse Drug Events from Electronic Health Record Notes (MADE 1.0)," Drug Safety, Springer, vol. 42(1), pages 99-111, January.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Likeng Liang & Jifa Hu & Gang Sun & Na Hong & Ge Wu & Yuejun He & Yong Li & Tianyong Hao & Li Liu & Mengchun Gong, 2022. "Artificial Intelligence-Based Pharmacovigilance in the Setting of Limited Resources," Drug Safety, Springer, vol. 45(5), pages 511-519, May.
    2. Hui Xing Tan & Chun Hwee Desmond Teo & Pei San Ang & Wei Ping Celine Loke & Mun Yee Tham & Siew Har Tan & Bee Leng Sally Soh & Pei Qin Belinda Foo & Zheng Jye Ling & Wei Luen James Yip & Yixuan Tang &, 2022. "Combining Machine Learning with a Rule-Based Algorithm to Detect and Identify Related Entities of Documented Adverse Drug Reactions on Hospital Discharge Summaries," Drug Safety, Springer, vol. 45(8), pages 853-862, August.
    3. Feifan Liu & Abhyuday Jagannatha & Hong Yu, 2019. "Towards Drug Safety Surveillance and Pharmacovigilance: Current Progress in Detecting Medication and Adverse Drug Events from Electronic Health Records," Drug Safety, Springer, vol. 42(1), pages 95-97, January.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:drugsa:v:46:y:2023:i:8:d:10.1007_s40264-023-01323-2. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com/economics/journal/40264 .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.